LAS VEGAS, NV - August 1, 2025 (NEWMEDIAWIRE) - NeuralBase AI Ltd. (OTC: NBBI), operating under its enterprise brand BMP AI, today announced that the Android version of HeartEase is now complete and undergoing final testing. The public release of the Android app is expected in the coming weeks, and the iOS version is scheduled to enter testing shortly thereafter.

HeartEase is designed to provide AI-powered cardiovascular and emotional health insights through intelligent monitoring, real-time feedback, and personalized wellness recommendations. The app leverages NeuralBase AI’s proprietary AI platform, behavioral insights, and biometric data analysis to create an adaptive user experience that supports proactive wellness management. 

“Achieving this development milestone marks an important step toward bringing HeartEase to the market,” said Vighnesh Dobale, Chief Executive Officer of NeuralBase AI Ltd. “We are pleased with the progress of the Android version and are preparing for the iOS testing phase, which will ensure feature parity and performance consistency across platforms.” 

The readiness of the Android version moves HeartEase closer to real-world deployment. Launching the app will:

• Validate the platform’s technology stack in real-world conditions.
• Provide essential user feedback to guide further refinements and enhancements.
• Lay the foundation for the iOS release and ensure platform consistency.
• Support potential strategic partnerships with healthcare providers, wellness platforms, and wearable technology companies.
• Position NeuralBase AI to scale its AI-powered digital health ecosystem as part of its broader mission to support enterprise wellness and preventive health diagnostics.

The Company will share further updates regarding HeartEase’s release schedule, platform enhancements, and strategic initiatives as testing progresses and new milestones are achieved.

The closing of the HeartEase transaction is expected by no later than September 15, 2025. NeuralBase will provide further updates if and when available, including filing all necessary disclosures with the Securities & Exchange Commission via EDGAR.

Additional information about NeuralBase AI Ltd. is available at https://www.neuralbase.ai or by visiting https://www.sec.gov.

About NEURALBASE AI LTD.

NeuralBase AI Ltd. (OTC: NBBI) is a publicly traded AI company focused on secure, scalable, and context-aware conversational systems and workflow automation. Through its BMP AI platform, currently in beta testing, the Company enables enterprises to streamline internal operations, enhance team collaboration, and improve productivity while maintaining compliance and data security.

Legal Disclaimer and Forward-Looking Statements

This press release contains forward-looking statements as defined under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements reflect current expectations, estimates, and projections of NeuralBase AI Ltd. (the “Company” or “NBBI”) based on assumptions and current market conditions. Forward-looking statements may include terms such as “aims,” “anticipates,” “expects,” “intends,” “plans,” “believes,” “may,” “will,” “could,” “should,” and similar expressions.

These statements relate, among other things, to the expected features and performance of the BMP AI platform; the timing and success of product development; potential industry applications; and overall strategic direction. All forward-looking statements are inherently subject to risks and uncertainties that may cause actual results to differ materially from those projected.

NeuralBase AI Ltd. is a fully reporting company with the U.S. Securities and Exchange Commission (SEC) and files annual and quarterly reports, current reports, and other required disclosures. All public filings and disclosures may be reviewed at the SEC’s EDGAR database at www.sec.gov. The Company trades on the OTC Markets under the ticker symbol NBBI.

This press release is not, and should not be construed as, an offer to sell or a solicitation of an offer to buy any securities of NeuralBase AI Ltd. in the United States or in any other jurisdiction. Offers and sales of securities, if any, will be made only pursuant to an effective registration statement or valid exemption under the U.S. Securities Act of 1933, as amended.

Investing in securities traded on the OTC Markets involves significant risk, including potential loss of principal, low liquidity, high volatility, and limited publicly available information. Shares traded on the OTC Markets may be more susceptible to market manipulation or price swings. Investors are strongly advised to conduct their own due diligence, consult a qualified investment advisor, and carefully review all SEC filings prior to making any investment decision.

 Media Contact:

Vighnesh Dobale
Chief Executive Officer
ir@neuralbase.ai
(727) 314-3717

View the original release on www.newmediawire.com